The global surrogacy market was valued at USD 194.0 Million in 2024 and is expected to reach USD 321.4 Million by 2033, exhibiting a CAGR of 5.48% during the forecast period 2025–2033. Growth is driven by rising infertility, fertility tourism, affordable surrogacy services, and supportive laws. Increasing societal acceptance and advancements in assisted reproductive technologies also contribute significantly to market expansion.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Surrogacy Market Key Takeaways
- Current Market Size: USD 194.0 Million (2024)
- CAGR: 5.48% (2025-2033)
- Forecast Period: 2025-2033
- Market growth is propelled by increasing infertility and awareness of surrogacy as an option.
- Gestational surrogacy dominates the market due to legal and psychological advantages.
- IVF with ICSI technology holds the largest share among reproductive technologies.
- Fertility clinics are the leading service providers, due to their expertise and facilities.
- North America leads the regional market due to supportive legal frameworks and advanced medical facilities.
Sample Request Link:
https://www.imarcgroup.com/surrogacy-market/requestsample
Market Growth Factors
The surrogacy market is primarily driven by the rising incidence of infertility and greater societal acceptance of surrogacy worldwide. Legal frameworks in many countries establish transparent and safe surrogacy processes, attracting more participants. Innovations in medical treatments, especially improvements in IVF success rates, bolster demand for surrogacy services. Additionally, increasing recognition of LGBTQ+ rights fuels growth through demand from homosexual couples wishing to have biological children. Economic factors, such as lower service costs in select regions, further support market expansion.
Key trends include the increasing prevalence of gestational surrogacy, which accounts for approximately 90% of all surrogacy arrangements, offering legal and psychological benefits by eliminating genetic connection between surrogate and child. Assisted reproductive technologies (ART), including IVF and genetic screening, enhance pregnancy success rates which range from 30% to 60% per embryo transfer in gestational surrogacy. Enhanced success rates, particularly with younger surrogates, drive greater demand.
The surrogacy market is also supported by changing societal norms fostering acceptance of diverse family forms. Studies indicate significant support for surrogacy among populations such as medical professionals and lawyers, exemplified by 54.8% and 52.9% support rates respectively in Lebanon. Reduction in social and cultural barriers and growing fertility tourism due to legal and cost differences worldwide create new opportunities. However, ethical concerns and varying regulations pose challenges to the market.
Market Segmentation
Type:
- Gestational Surrogacy: Surrogate carries a pregnancy conceived from eggs and sperm of the intended parents or donors. It reduces genetic connection between surrogate and child, solving legal and psychological challenges and enabling access for same-sex couples and genetic diversity. Driven by advances in assisted reproductive technologies.
- Traditional Surrogacy: Not separately described in detail; represents the other segment.
Technology:
- IVF with ICSI: Sophisticated assisted reproductive technology involving direct sperm injection into egg to overcome male infertility, holding the largest market share. High success rates make surrogacy reliable and applicable to a wider demographic.
- IVF without ICSI: Not described in detail.
- Intrauterine Insemination: Not described in detail.
Service Provider:
- Hospitals: Not separately detailed.
- Fertility Clinics: Represent the largest segment, providing advanced reproductive technologies, full assessments, treatment plans, and close legal and medical collaboration ensuring smooth and successful surrogacy.
- Others: Not described in detail.
Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Regional Insights
North America dominates the surrogacy market owing to its supportive legal environment and advanced medical infrastructure. Countries like the United States and Canada provide clear regulations that safeguard intended parents, surrogates, and resultant children, attracting both domestic and international intended parents. The region features a tolerant social setting and proficient medical personnel in assisted reproductive technologies, reinforcing its market leadership.
Recent Developments & News
In June 2021, Circle Surrogacy & Egg Donation sponsored "A Lifetime of Pride and Joy," a campaign supporting family equality and raising fertility care accessibility awareness among the LGBTQ+ community. In June 2023, Nova IVF Fertility announced plans to establish 100 centers in India over four years to expand fertility care access. In October 2022, Ovation Fertility partnered with Genomic Prediction to enhance genetic testing and reproductive options, leveraging scientific advancements for intended parents.
Key Players
- Bourn Hall Fertility Clinic
- Care Fertility
- Circle Surrogacy
- Extraordinary Conceptions
- Growing Generations
- Houston Fertility Center
- IVIRMA Global
- Kindbody
- Max Healthcare
- New Hope Fertility Clinic
- Nova IVF
- Ovation Fertility
Customization Note
https://www.imarcgroup.com/request?type=report&id=5298&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
